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Abstract—Amyotrophic lateral sclerosis (ALS) is a fatal
neurodegenerative disease that leads to motor neuron degen-
eration, alteration in neuromuscular junctions (NMJs),
muscle atrophy, and paralysis. To investigate the NMJ
functionality in ALS we tested, in vitro, two innervated
muscle types excised from SOD1G93A transgenic mice at the
end-stage of the disease: the Soleus, a postural muscle almost
completely paralyzed at that stage, and the diaphragm,
which, on the contrary, is functional until death. To this aim
we employed an experimental protocol that combined two
types of electrical stimulation: the direct stimulation and the
stimulation through the nerve. The technique we applied
allowed us to determine the relevance of NMJ functionality
separately from muscle contractile properties in SOD1G93A
animal model. Functional measurements revealed that the
muscle contractility of transgenic diaphragms is almost
unaltered in comparison to control muscles, while transgenic
Soleus muscles were severely compromised. In contrast, when
stimulated via the nerve, both transgenic muscle types
showed a strong decrease of the contraction force, a slowing
down of the kinetic parameters, as well as alterations in the
neurotransmission failure parameter. All together, these
results conﬁrm a severely impaired functionality in the
SOD1G93A neuromuscular junctions.
Keywords—Muscle functional measurements, Nerve stimu-
lation vs. direct stimulation, Neurotransmission failure,
Intratetanic fatigue, ALS.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a disease that
leads to motor neuron degeneration, muscle atrophy
and paralysis.23,43 Although different pathogenic
mechanisms have been proposed to account for ALS,40
several questions are still open and ALS remains an
invariably fatal disease. The heterogeneity of the disease
and failures in developing satisfactory therapeutic pro-
tocols reinforce the view that ALS is a multi-factorial
and multi-systemic pathology.34,47 Recent studies on
ALS animal models showed that the physiological
connection between muscle and nerve is severely
impaired,16,34 suggesting that the neuromuscular junc-
tion (NMJ) might be a direct target of the SOD1-medi-
ated toxicity.10,13,19,35 Measuring NMJ functionality in
ALS models, along with morphological and biochemi-
cal evaluations, should provide new insights on the
physiopathologic interplay between muscle and nerve,
and on the progression of the disease. Although the
SOD1G93A mouse is one of the most studied animal
models for ALS,21 its skeletal muscle contractile prop-
erties have been poorly investigated and the NMJ
functionality not elucidated. Previous studies on
SOD1G93A mice reported a deﬁcit of the extensor digito-
rum longus (EDL) in generatingmaximum force after the
onset of the pathology12,24 and a trend toward lower
values of maximum speciﬁc force in diaphragm strips,24
whencompared towild type littermates.Those studies did
notdeterminewhether the alterationsweredue tochanges
either in muscle or in neuromuscular transmission.
Here we studied two diﬀerent muscle-nerve prepa-
rations at the end-stage of the disease: the Soleus with
its sciatic nerve, and the diaphragm with its phrenic
nerve. The Soleus is a postural muscle composed of
about 60% of fast ﬁbers and 40% of slow ﬁbers5 and is
found to be almost completely paralyzed at the disease
end-stage. On the other hand, the diaphragm is func-
tional until death, usually caused by diaphragmatic
failure and hypoventilation in both animal models and
human patients.17
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NMJ functionality can be measured, in isolated
in vitro muscle-nerve preparations, by comparing the
contractile response elicited by nerve electrical stimu-
lation with the response of the same muscle evoked by
direct stimulation of the membrane.2,18 Since this latter
stimulation bypasses the neurotransmission signalling,
any differences in the two contractile responses can be
attributed to changes in the NMJ. Although this
approach has been used in rats,33,37,45 there have been
only a few studies in which it has been used in mice.
Personius and Sawyer measured the diaphragm NMJ
functionality in adult mdxmice,36 while Lee et al.26 and
Ling et al.27 measured NMJ properties in the Soleus
and in the EDL of an animal model of spinal muscle
atrophy (SMA).
Thus, the main goal of this work was to evaluate the
potential alterations of neuromuscular junction and
muscle contraction in SOD1G93A vs. wild type mice,
analyzing the functional properties of two different
muscle types. To accomplish this, we chose to measure
the contractile properties of isometric twitches, the
force-frequency relationship and the fatigue behavior.
MATERIALS AND METHODS
Experimental procedure
All experiments were conducted in accordance with
the Italian Law which governs the use of animals in
experimentation, and the procedure was approved by
the local ethics review board. Both male and female
wild-type C57BL/6 (WT) and transgenic SOD1G93A
mice were used in this study. The mice were sacriﬁced
at 130–140 days of age. This age was chosen because it
is close to the age at which SOD1G93A mice normally
die spontaneously. They were killed by cervical dislo-
cation to minimize suffering. Immediately after sacri-
ﬁcing the mice, muscles were excised for testing. One
muscle specimen was tested from each animal. The
surgical excision of muscle-nerve samples was carried
out in a dissecting bath containing a Bicarbon-
ate—buffered storage solution11 continuously gassed
with a mixture of 95% O2 and 5% CO2 at pH 7.4 and
at room temperature.
The diaphragm: the muscle was isolated and the
phrenic nervewas separated from the surrounding tissue
for approximately 5 mm. Themuscle and nerve were cut
and removed. We then cut a strip of the excised muscle,
for testing. The stripwas cut parallel to themuscle ﬁbers,
with ribs at one end and central tendon at the other end,
and was approximately 2–3 mm wide.
The Soleus: right and left Soleus muscles were
removed along with 5 mm of their sciatic innervation.
The Achilles’ tendon was cut as close as possible to the
calcaneus and the entire triceps surae was removed. It
was immediately put in the physiological bath and
pinned to a silicon substrate. The proximal tendon of
the Soleus was then gently pulled to separate the
muscle from the surrounding tissues. Once the muscle
was completely exposed, and the sciatic innervation
separated, the distal tendon was cut. Both muscles
were excised in order to increase the likelihood that at
least one specimen would not have been damaged by
the surgical procedure, but only one Soleus was tested
for each animal.
Experiments were conducted using the following
number of muscles: 11 WT and 8 SOD1G93A Soleus,
and 8 WT and 8 SOD1G93A diaphragm strips. The
muscle to be tested was vertically mounted in an oxy-
genated and temperature controlled chamber (30 C
for Soleus3,11 and 27 C for diaphragm36) containing
the same solution used in the dissecting bath. One end
of the muscle was linked to a ﬁxed clamp while the
other end was connected to the lever-arm of a 300B
actuator/transducer (Aurora Scientiﬁc Inc., ON, Can-
ada). Each muscle was set up so it could be activated
either by stimulating its nerve, or by direct stimulation.
For nerve-evoked muscle activation, the nerve was
sucked into a suction electrode (A-M Systems Inc.,
Sequim, WA) and supramaximal pulses were delivered
to the nerve by a 701B stimulator (Aurora Scientiﬁc
Inc., ON, Canada). For direct activation, two platinum
electrodes were located 2 mm from each side of the
muscle, while electrical stimuli were supramaximal
current pulses of 300 mA, generated by a 701C stim-
ulator (Aurora Scientiﬁc Inc., ON, Canada).11 A per-
sonal computer equipped with a NI PCIe-6353
acquisition board (National Instruments, Austin, TX)
and programmed in LabVIEW 2012 (National
Instruments, Austin, TX) synchronized the signals and
the data acquisition for the entire length of the
experiment. The custom-made software allowed for
choosing all the stimulating parameters: the stimulat-
ing electrodes to use (nerve vs. direct), the pulse width,
the stimulation frequency, the pulse train duration and
the rest period between two consecutive pulse trains.
The software was designed to guarantee high ﬂexibil-
ity, accuracy, and repeatability of the stimulations.
Synchronization between the signals delivered to the
muscles and the acquired signals was evaluated with a
TDS2014 digital oscilloscope (Tektronix Inc, Beaver-
ton, OR). Results highlighted a maximum value of
phase lag less than 10 ls, which resulted negligible for
the acquisition frequencies used in this study.
Experimental protocol
To extensively investigate the neuromuscular junc-
tion functionality of Soleus-sciatic and diaphragm-
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phrenic nerve preparations, we established a continu-
ous experimental protocol to measure several funda-
mental parameters of both muscle contractility and
junction functionality.
Initial control experiments: we wished to demon-
strate that (a) direct stimuli did not activate the muscle
by stimulating intra-muscular branches of the nerve
and (b) that stimuli applied to the nerve through the
suction electrode did not activate the muscle artifac-
tually, by spread of current in the bath. Therefore, in
several control experiments utilizing both diaphragm
and Soleus muscles, we measured muscle contractile
response before and after adding D-tubocurarine
(25 lM) to the physiological bath.30 We found that
D-tubocurarine completely silenced the specimen
response to nerve stimulation, and did not signiﬁcantly
alter the muscle response to direct stimulation (data
not shown). The above observations veriﬁed that the
contraction caused by direct muscle stimulation was
not mediated by the nerve stimulation pathway. In
addition, we also wished to verify that the electric
pulses delivered through the suction electrode did not
spread in the solution, generating a current ﬁeld strong
enough to directly excite the muscle.7 Therefore, at the
beginning of each experiment, we applied a few single
pulses through the suction electrode before pulling the
nerve in. We observed that supramaximal current
pulses in the range of 5–10 mA did not excite the
muscle membrane but, once the nerve was pulled in,
were strong enough to activate the nerve and elicit
muscle contraction. These were the current values we
used for all nerve stimulation experiments.
In another set of preliminary experiments we
determined the optimal pulse width for nerve stimu-
lations, for both sciatic and phrenic nerves. We mea-
sured the relationship between the width of single
stimulation pulses and the speciﬁc force, in ten Soleus
and eight diaphragm muscle-nerve preparations. Pulse
widths varied between 0.2 and 2.2 ms. In diaphragm,
speciﬁc twitch force was maximal when using a pulse
width of 1.8 ms, a value very close to that used by
Personius and Sawyer36 (2.0 ms). In Soleus, speciﬁc
twitch force was maximal using a pulse width of
1.4 ms. Since this value is slightly higher than that used
by Lee et al.26 (1.0 ms) for Soleus in young mice, we
performed additional preliminary experiments. We
subjected seven Soleus muscles to three pulse trains at
the tetanic frequency of 80 Hz: the ﬁrst train was
delivered directly to measure the maximum force, and
the other two were delivered through the nerve with a
pulse width of 0.2 and 1.4 ms, respectively. Results
showed that only when stimulating the preparation
with 1.4 ms pulses all the specimens were able to gen-
erate their maximum force. Accordingly to all these
tests, we used a pulse width of 1.8 ms for phrenic nerve
stimulation and 1.4 ms for sciatic nerve stimulation.
Direct stimulation of diaphragm and Soleus used
pulses of 0.230 and 0.1 ms, respectively.4,11
Once the optimal stimulation parameters were
determined, we designed an experimental protocol to
gather all the desired data in the shortest time. The
protocol we ended up with consists of four parts: (1) a
single pulse stimulation sequence, (2) an evaluation of
the force-frequency relationship, (3) a fatigue para-
digm at a physiologic ﬁring frequency, and (4) a fatigue
paradigm at the fused tetanic frequency. While the
protocol structure is the same for the two muscle types,
the stimulation parameters, namely the pulse width,
the train duration and the rest periods, diﬀer when the
protocol refers to Soleus or diaphragm muscles. An
example of the forces measured during the entire
protocol for a wild-type Soleus is shown in Fig. 1. In
the ﬁrst part, the muscle was stimulated with four
single pulses, one delivered directly and one through
the nerve, repeated twice, with a rest period of 30 s
between each. Time to peak (TTP), half relaxation time
(½RT), maximum value of force derivative (dF/dt) and
twitch force (Ftw) were then measured from the twitch
responses. After a rest period of 120 s, we stimulated
the specimen with a series of pulse trains in the range
between 20 Hz and the tetanic frequency, to compute
the force-frequency curves for both nerve and direct
stimulations. In particular, since the tetanic frequency
is 80 Hz for Soleus6 and 100 Hz for diaphragm,36 we
stimulated all the specimens using the following shuf-
ﬂed sequences: for Soleus muscles, N40 Hz (through
the nerve), M60 Hz (direct on the membrane), N80,
M20, N60, M80, N20, and M40 Hz; for diaphragm
muscles, N60, M100, N40, M20, N80, M80, N20, M40,
N100, and M60 Hz. The rest periods imposed after
each stimulation were established with preliminary
experiments. For each muscle, the un-fatigued maxi-
mum force was measured and taken as reference value.
The rest periods were then determined as the minimum
pause that allowed the muscle to recover its capability
of generating maximum force. For Soleus muscles this
rest time was equal to 3 min for all the stimulation
frequencies, while for diaphragm muscles it was pos-
sible to reduce the rest periods accordingly to the
stimulation frequency: 180 s rest time after tetanic
stimulation, 150 s after the 80 Hz stimulation and only
120 s after all the other stimulations. After a rest time
of 5 min, in the third and fourth parts of the protocol,
the muscle was subjected to two fatigue paradigms in
order to measure the neurotransmission failure (NF) at
two different frequencies.25,36 The rest time between
the two fatigue paradigms was considered appropriate
when the force generated by the muscle at the begin-
ning of the tetanic fatigue paradigm was at least 90%
of the maximum force the same specimen generated
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during the force frequency measurements. We esti-
mated an appropriate rest time of 15 min for both
muscle types, as shown in Fig. 1 for a wild-type Soleus
muscle.
Diaphragm stimulation: the parameters used during
the ﬁrst fatigue paradigm to measure the neurotrans-
mission failure at the ﬁring frequency were derived
from Personius and Sawyer36: one 0.33 s pulse train at
35 Hz delivered directly, followed by fourteen 0.33 s
pulse trains at 35 Hz delivered through the nerve, with
a rest period of 0.67 s after each pulse train. This se-
quence was repeated 20 times for an overall stimula-
tion period of 5 min.
Soleus stimulation: the protocol parameters were
determined with preliminary experiments. In fact, be-
cause of Soleus ﬁber composition,15,41 longer pulse
trains are required to stimulate the muscle at its max-
imum force. The resulting fatigue paradigm at ﬁring
frequency was as follows: one 0.8 s pulse train at 35 Hz
delivered directly, followed by fourteen 0.8 s pulse
trains at 35 Hz delivered through the nerve, with a rest
period of 1.2 s after each pulse train. Just as for the
diaphragm, this sequence was repeated 20 times,
resulting in an overall fatigue paradigm time of 10 min.
The neurotransmission failure was then computed for
both muscle types asNF ¼ FMF1MF%, where F is the force
decreasemeasured after nerve stimulation andMF is the
force decrease following muscle stimulation.25,36
For the second fatigue paradigm, the pulse train
duration, the rest period and the number of repetitions
were the same as in the previous one, but the stimu-
lation frequency was now set to 80 Hz for the Soleus
and to 100 Hz for the diaphragm. During this para-
digm, we also measured the intra-tetanic fatigue (IF) as
proposed by van Lunteren et al. for rat diaphragm.45
IF is given by the force at the end of the pulse train as
percent of the maximum force generated during that
same pulse train. As regards to the nerve stimulation,
the intra-tetanic fatigue was computed on the ﬁrst
pulse train immediately after the direct stimulation.
The entire length of the protocol was about 65 min for
the Soleus and about 55 min for the diaphragm. Of
note, in a previous paper we demonstrated that ex vivo
skeletal muscle preparations kept in an appropriate
bath, did not undergo any signiﬁcant alterations over
comparable time periods even if subjected to highly
demanding stimulation protocols.11
For each experiment, the initial muscle length was
adjusted to the length (L0) which produced the highest
twitch force. At the end of the protocol, net muscle
length and weight were measured using an analog
calliper, with an accuracy of 0.05 mm, and a Pioneer
precision scale (Ohaus, Parsippany, NJ), with an
accuracy of 0.1 mg. Cross Sectional Area (CSA) for
force normalization was estimated dividing the muscle
mass by the product of Lf and the density of mam-
malian skeletal muscle (1.06 mg/mm3). Lf is the opti-
mal ﬁber length and was obtained by multiplying L0
for the ﬁber length to the muscle length ratio (0.71 for
Soleus6 and 1 for diaphragm muscle31).
FIGURE 1. Example of a complete stimulation protocol showing the force values recorded from a wild-type Soleus. The muscle is
initially stimulated with four single pulses (Tw), delivered alternatively one directly and one through the nerve. Subsequently, a
series of eight pulse trains are delivered to the specimen at the indicated frequency, alternatively directly and through the nerve to
measure the force-frequency curves. The protocol ends up with two fatigue paradigms: the first delivered at the firing frequency
(35 Hz) and the second at tetanic frequency (80 Hz). Insets show stimulation pulses and force response curves on a magnified time
scale.
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Statistical Analysis
Statistical analyses were performed separately on
Soleus and diaphragm data. Diﬀerences in the values
of muscle weight, length and CSA were evaluated with
Student’s t tests. Since in our analyses we studied a
continuous outcome on the basis of categorical vari-
ables, we referred to Analysis of Variance to identify
any signiﬁcant differences between the means of tested
groups. Differences in the values of TTP, ½RT and
dF/dt were evaluated with 2-way ANOVAs using the
factors animal strain and stimulation type. When the
2-way ANOVA indicated signiﬁcant differences, we
used multiple t tests to look for statistical differences.
Similarly, differences in force-frequency curves and in
the intra-tetanic fatigue were evaluated with a 3-way
ANOVA using the factors animal strain, stimulation
type and frequency of stimulation or time. When the
3-way ANOVA indicated a signiﬁcant effect of the
factors animal strain and stimulation type, we applied a
2-way ANOVA to identify signiﬁcant differences
between transgenic and control specimens stimulated
directly, and between transgenic specimens stimulated
directly and through the nerve. Differences in the
neurotransmission failure were evaluated using a two-
way ANOVA with reference to the ﬁxed factors stim-
ulation type and time. Statistical analyses was per-
formed with GraphPad Prism 6.0 and SPSS 17.0 and
differences were considered signiﬁcant when p< 0.05.
RESULTS
Values of muscle weight, length and estimated CSA
are reported in Table 1 for SOD1G93A and WT Soleus.
Transgenic muscles from 130 to 140 day-old mice
displayed, on average, a 24% decrease in muscle
weight (p< 0.001) and a 7% decrease in muscle length
(p< 0.05), which resulted in a decrease of 18% of
muscle CSA (p< 0.01), in comparison to wild type
littermate.
Twitch response features of Soleus muscles stimu-
lated directly and through the nerve in WT and
SOD1G93A animals are shown in Fig. 2. TTP (Fig. 2a)
and ½RT (Fig. 2b) were signiﬁcantly greater in
SOD1G93A muscles, indicating that the isometric
twitch was slower to rise and slower to decay than in
WT. SOD1G93A muscles also had a lower rate of force
generation, dF/dt (Fig. 2c), and dF/dt was even smaller
with nerve stimulation than with direct stimulation.
Twitch response features of WT and SOD1G93A dia-
phragm muscles stimulated directly and through the
nerve are shown in Fig. 3. Transgenic diaphragms
showed signiﬁcantly longer TTP (Fig. 3a) and lower
dF/dt (Fig. 3c) only in nerve-evoked twitches.
Force-frequency curves, from single pulse to tetanic
frequency, are shown in Fig. 4. Both Soleus (Fig. 4a)
and diaphragm (Fig. 4b) SOD1G93A muscles developed
speciﬁc forces signiﬁcantly lower than WT, regardless
of stimulation frequency. Direct stimulation of
SOD1G93A Soleus muscles revealed a reduction, on
average, of 25% (p< 0.001) in the maximum speciﬁc
force when compared to WT. Interestingly, a further
average decrease of 46% (p< 0.001) was found for
SOD1G93A Soleus maximum speciﬁc force measured
with nerve stimulation, when compared to the response
of the same transgenic muscle stimulated directly.
Transgenic Soleus maximum speciﬁc force measured
by nerve stimulation was then reduced by 57%, on
average, when compared to WT (p< 0.001). A gen-
erally similar result was observed when testing dia-
phragm strips (Fig. 4b). Moreover, a signiﬁcant
difference (p< 0.01) emerged between the force-fre-
quency curves measured for transgenic and WT mus-
cles when stimulated directly. For SOD1G93A muscles
there was also a signiﬁcant difference between the di-
rect and the nerve stimulation curves (p< 0.001).
Analysis of SOD1G93A diaphragm maximum speciﬁc
forces showed only a trend toward lower values when
directly stimulated (p ~ 0.1), while a strong decrease of
44%, on average, was found when diaphragm was
stimulated through the nerve (p< 0.001). Therefore,
SOD1G93A diaphragm maximum speciﬁc force mea-
sured through nerve stimulation resulted reduced, on
average, of 50% when compared to WT diaphragm
stimulated in the same way (p< 0.001).
Figure 5 shows the average values of intratetanic
fatigue (IF) measured during the tetanic fatigue para-
digm for Soleus (Fig. 5a) and diaphragm strips
(Fig. 5d). For both muscle types, the 3-way ANOVA
revealed that all the ﬁxed factors, animal strain, stim-
ulation type and time, signiﬁcantly affected the IF.
Neither Soleus nor diaphragm, in both WT and
SOD1G93A animals, exhibited any intratetanic fatigue
when studied with direct stimulation. Therefore, the IF
results described here below are only for nerve stimu-
lation experiments. Regarding Soleus muscle, the 2-
way ANOVA revealed that IF was signiﬁcantly af-
fected only by the ﬁxed factor time (p< 0.001). A
closer analysis of the force curves measured for each
pulse train highlighted a limitation of the method when
computing intratetanic fatigue at the end of the pro-
TABLE 1. Anatomical measurements for WT and SOD1G93A
Soleus.
Soleus Weight (mg) Length (mm) CSA (mm2)
WT 7.77 ± 0.32 10.92 ± 0.18 0.94 ± 0.03
SOD1G93A 5.88 ± 0.33 10.18 ± 0.22 0.77 ± 0.04
Values are mean ± SEM.
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tocol. At the beginning of the 80 Hz fatigue paradigm
the forces generated by transgenic muscles were always
higher than 80 mN (see Fig. 5b) allowing a reliable
measurement of the force decrease within the same
pulse train. At the end of the paradigm, on the con-
trary, the muscles were exhausted and the contraction
forces were near zero, especially for atrophic muscles
like SOD1G93A (see Fig. 5c): in this situation, the
sensitivity of the method was reduced to zero and the
IF values obtained with the calculation, from this point
on, basically expressed noise. Therefore, the 2-way
analysis of variance was performed taking into account
FIGURE 2. Twitch response properties of control (WT) and transgenic (SOD) Soleus muscles stimulated directly (M) and through
the nerve (N). Shown are the mean 6 SEM of the TTP (a), the ½RT (b) and the dF/dt (c). SOD is for SOD1G93A. * and **: p< 0.05 and
p< 0.01 vs. WT M; # and ###: p< 0.05 and p< 0.001 vs. WT N; +++: p< 0.001 vs. SOD M.
FIGURE 3. Twitch response properties of control (WT) and transgenic (SOD) diaphragm muscles stimulated directly (M) and
through the nerve (N). Shown are the mean 6 SEM of the TTP (a), the ½RT (b) and the dF/dt (c). SOD is for SOD1G93A. #: p<0.05 vs.
WT N; + and ++: p< 0.05 and p< 0.01 vs. SOD M.
FIGURE 4. Relationship between specific force and frequency of stimulation from single pulse to tetanus, for Soleus (a) and
diaphragm (b) specimens. M indicates direct membrane stimulation, N indicates nerve stimulation. For both muscle types, the SOD
M curve was significantly different from the WT M and the SOD N curve was significantly lower than the SOD M. Values are
mean 6 SEM. SOD is for SOD1G93A. ** and ***: p<0.01 and p< 0.001 vs. WT M; +++: p< 0.001 vs. SOD M.
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only the ﬁrst 8 min of stimulation of the 80 Hz fatigue
paradigm, where the measured forces were always
higher than 5 mN. Within this limitation, IF was sig-
niﬁcantly affected also by the ﬁxed factor animal strain
(p< 0.05) and was lower in the SOD1G93A group.
Statistical analysis of IF measured during the 100 Hz
fatigue paradigm for diaphragm strips revealed that IF
was signiﬁcantly affected by the ﬁxed factors time and
animal strain, even taking into account the values
measured until the end of the paradigm. In fact, WT
and transgenic diaphragm specimens were able to
generate remarkable forces both at the beginning
(Fig. 5e) and at the end (Fig. 5f) of the fatigue para-
digm. Finally, it should be noted that a very high
variability was observed for IF in both transgenic So-
leus and diaphragm specimens when stimulated
through the nerve.
Figure 6 shows the neurotransmission failure at te-
tanic frequency measured for Soleus (Fig. 6a) and
diaphragm (Fig. 6b) specimens. Soleus NF was af-
fected only by the ﬁxed factor time, while diaphragm
NF resulted signiﬁcantly affected by the factors animal
strain and time. Diaphragm specimens hence presented
a signiﬁcant increase of the neuromuscular junction
fatigability. For the same limitation explained above
for the Soleus IF, the NF values for Soleus muscle were
considered only until the 8th min of stimulation.
Similar results were reported for the neurotrans-
mission failure measured at the ﬁring frequency, as
shown in Fig. 7. Once again Soleus NF (Fig. 7a)
resulted affected only by the factor time, while dia-
phragm NF (Fig. 7b) was affected by both animal
strain and time factors.
DISCUSSION
The aim of this work was to characterize the neu-
romuscular junction functionality of the SOD1G93A
transgenic mice,21 an animal model of ALS disease, at
the very last stage of its lifespan. To do this, we tested
two muscle types severely but differently affected by
ALS, the Soleus and the diaphragm. The marked de-
crease we measured at this stage of the disease for the
Soleus length and weight substantiates how much this
muscle type is affected by the atrophic process induced
by ALS. On the other hand, due to the arbitrariness
with which they were cut, the diaphragm strips we
tested cannot be considered representative of the
muscle morphology, and it was not possible to corre-
late the anatomical measurements of the strips with the
atrophic process on this muscle type. The absolute
length and weight measured for the diaphragm strips
are therefore meaningless, and only normalized
FIGURE 5. Analysis of intratetanic fatigue computed for Soleus (a) and diaphragm (d) muscles. Force values measured with nerve
stimulation at the beginning of the protocol allows for a reliable IF measurement for both SOD1G93A Soleus (b) and diaphragm (e).
At the end of the protocol the force generated by transgenic Soleus drops down near zero (c) therefore, from this point on, the
values of IF expresse noise. Thus, statistical analysis has been performed taking into account only the first 8 min of stimulation, as
indicated by the dotted line in (a), were the contraction forces are higher than 5 mN. On the contrary, forces generated by
diaphragm specimens allow for a good IF measurement until the end of the protocol (f). Values are mean 6 SEM. SOD is for
SOD1G93A. # and ##: p< 0.05 and p< 0.01 vs. WT N.
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parameters such as speciﬁc forces, df/dt, IF and NF can
provide useful results.
Of note, the Soleus muscles in 130–140 day-old
SOD1G93A mice are almost completely para-
lyzed,14,21,29 while the diaphragm is functional until
death. The results we obtained with direct stimulation
experiments correlate well with these observations.
Indeed, the Soleus muscle showed a signiﬁcant de-
crease of the contractile kinetics and of the speciﬁc
forces, while the diaphragm presented only modest
alterations of the same properties.24 Despite this dif-
ference in the response to direct stimulation, both
muscle types showed a signiﬁcant defect in their con-
tractile response when stimulated via the nerve. A
slowing down of the contractile parameters, a dramatic
reduction of the speciﬁc forces and an increased sus-
ceptibility to NMJ fatigue are, in fact, common fea-
tures.
In addition to the dramatic decrease of speciﬁc
forces, a change of the tetanic frequency occurred in
both muscle types. Soleus and diaphragm tetanic fre-
quency moved toward lower values, in agreement with
the slowing down of the kinetic parameters measured
with single pulse stimulations. Although the change of
the tetanic frequency was limited for Soleus and dia-
phragm muscles when directly stimulated, it was quite
big for diaphragm muscles when stimulated through
the nerve. A pulse train frequency of 40 Hz was suﬃ-
cient to elicit muscle maximum speciﬁc force. All to-
gether these results show that the two muscle types we
tested have a slower phenotype than their WT coun-
terparts.
Even though denervation is usually associated with
a shift toward fast ﬁbers,9 controversial results are also
reported in the literature. For example, Agbulut et al.1
showed that sciatic nerve excision did not alter the WT
Soleus MHC-1 protein content, but induced a slowing
down of the functional kinetic parameters. A similar
result was observed by Raffaello et al.39 in WT
denervated EDL, who reported a slowing down of the
FIGURE 6. Neurotransmission failure computed at the tetanic frequency of 80 Hz for Soleus (a) and 100 Hz for diaphragm (b)
specimens. NF values for Soleus muscle should be considered reliable only until the 8th min of stimulation, as indicated by the
dotted vertical line (a), where the forces generated by the muscle specimens were higher than 5 mN. Values are mean 6 SEM. SOD
is for SOD1G93A. *: p< 0.05 vs. WT.
FIGURE 7. Neurotransmission failure computed at the firing frequency of 35 Hz for Soleus (a) and diaphragm (b). Values are
mean 6 SEM. SOD is for SOD1G93A. ***: p< 0.001 vs. WT.
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kinetic parameters. Moreover, it has to be considered
that the mouse model we studied in this work is a
model of chronic denervation, where progressive death
of motor neurons results both in denervation and in re-
innervation of the muscles. In particular, it has been
shown20,38 that, in SOD1G93A mice, the large-diameter
motor axons degenerate ﬁrst, leading to denervation of
fast muscle ﬁbers. Selective degeneration of motor
neurons with large-diameter axons was also shown by
Hegedus et al.22,23, who reported early loss of fast
fatigable motor units and survival of slow motor units.
Therefore, the small-diameter motor axons which
innervate slow muscle ﬁbers are mainly responsible for
re-innervation of vacant endplates, a process that can
alter any ﬁber shift due to denervation. In view of all
these reasons, we believe that the functional results
here reported point out a comprehensive character-
ization of the muscle phenotype, thus involving ﬁber
shift, denervation and re-innervation processes and ﬁ-
ber degeneration.
As regards to NMJ fatigability, it is well expressed
by the intratetanic fatigue, which is an estimate of the
muscle’s capability of maintaining force during a single
tetanic contraction, and reﬂects the high-frequency
fatigue. Our results showed that the stimulation
through the nerve induced an increase of the suscep-
tibility to fatigue up to 30% for Soleus and up to 50%
for diaphragm muscles, respectively. This observation
suggests that there might be some mechanism involved
in the fast response of muscles to the stimuli, such as a
decreased transmitter release. Of note, when subjected
to direct stimulation, both WT and SOD1G93A muscles
did not undergo to any IF, supporting the hypothesis
that a defect in biochemical signaling from the nerve
occurred. Electrophysiological analysis performed by
Mancuso et al. on SOD1G93A mice plantar and tibialis
anterior muscles demonstrated a slowing down of
motor nerve ﬁber conduction,32 a result that supports
our outcomes and conﬁrms that common defects can
be found in different muscle types.
As a matter of fact, the only parameter that exhibits
diﬀerent results for the two muscle types we tested is
the neurotransmission failure, which is believed to play
an important role in the development of fatigue, being
related to axonal block of action potential propaga-
tion, decreased transmitter release or decreased end-
plate excitability.44 The values of NF we measured with
tetanic stimulation for WT diaphragms are in accor-
dance with the ones from Personius and Sawyer.36
Since we measured NF at the end of the entire stimu-
lation protocol, this outcome strengthens our hypoth-
esis that the sequence of stimulation pulse trains and
resting times proposed here did not induce fatigue in
the tested muscles. NF measured at 35 Hz, on the
contrary, differs from the values reported by Personius
and Sawyer, who did not report alterations for WT
diaphragms. Nonetheless, it has to be noted that they
measured NF in a different way, testing the muscles
with two separate paradigms, one stimulating directly
the muscle and the other stimulating it through the
nerve. Moreover, their results come from a low num-
ber of samples, thus showing high error bars. Indeed,
other researchers42,44 reported for rat diaphragm val-
ues of NF that are in agreement with the ones we
measured here.
Our experiments showed that NF remains unaltered
in the Soleus and is signiﬁcantly increased in the dia-
phragm, both at subtetanic and tetanic frequencies.
This dissimilarity can be explained considering that at
the disease end-stage the contractile capability is se-
verely compromised in Soleus muscles, thus dominat-
ing any effects of NMJ deﬁcits on the contractile
measurements. In diaphragms, in contrast, muscle
contractile properties are preserved even at the late
stage of the pathology, and the defects due to neuro-
muscular transmission can therefore be distinguished.
In fact, our results correlate well with biological, bio-
chemical and electrophysiological evaluations already
reported in the literature, according to which both
muscle types should undergo intratetanic fatigue. A
decrease of the estimated motor units number com-
pared to the number of spinal cord motor neurons in
gastrocnemius muscles,35 and a signiﬁcant denervation
of end-plates in transgenic Soleus, tibialis anterior,
gastrocnemius and diaphragm muscles8,19,46 have been
observed by others. In addition, it has been shown
that, by day 80, the density of intact motor axons was
markedly reduced in the ventral root, as well as a
vacuolation of large motor neuron cell bodies, indi-
cating that active degeneration was ﬁrst observed.19,46
Finally, Llado et al.28 studied the electrophysiologic
and pathologic properties of cervical motor neurons
and phrenic nerves in mutant SOD1G93A rats showing
motor neuron loss, progressive reduction of phrenic
nerve compound muscle action potential amplitudes,
phrenic nerve ﬁber loss and diaphragm atrophy. Our
ﬁndings conﬁrmed the damages in the phrenic nerve
ﬁber conduction. With our tests, we were able to dis-
criminate between alterations in neuromuscular
transmission and alterations in the diaphragm’s con-
tractile capability, which remained substantially unal-
tered despite the compromised condition of SOD1G93A
animals.
In conclusion, we devised an experimental protocol
to measure NMJ functionality in SOD1G93A mice, and
our results elucidated changes in NMJ functionality
separately from those in the muscle contractile prop-
erties. The NMJ changes we measured with this tech-
nique could not clarify which part of the nerve
stimulation pathway was altered, but the results clearly
RIZZUTO et al.2204
pointed out that a slowing down of the contractile
kinetics, a decrease in the capability of generating force
when stimulated through the nerve and an increase of
intratetanic fatigue can be considered common signs of
those muscle districts affected by ALS progression.
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